BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9628428)

  • 1. Prognostic significance of TEL/AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia.
    Takahashi Y; Horibe K; Kiyoi H; Miyashita Y; Fukuda M; Mori H; Nozaki C; Hasegawa S; Kawabe T; Kato K; Kojima S; Matuyama T; Naoe T
    J Pediatr Hematol Oncol; 1998; 20(3):190-5. PubMed ID: 9628428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
    Seeger K; Adams HP; Buchwald D; Beyermann B; Kremens B; Niemeyer C; Ritter J; Schwabe D; Harms D; Schrappe M; Henze G
    Blood; 1998 Mar; 91(5):1716-22. PubMed ID: 9473238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.
    Borkhardt A; Cazzaniga G; Viehmann S; Valsecchi MG; Ludwig WD; Burci L; Mangioni S; Schrappe M; Riehm H; Lampert F; Basso G; Masera G; Harbott J; Biondi A
    Blood; 1997 Jul; 90(2):571-7. PubMed ID: 9226156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong.
    Tsang KS; Li CK; Chik KW; Shing MM; Tsoi WC; Ng MH; Lau TT; Leung Y; Yuen PM
    Am J Hematol; 2001 Oct; 68(2):91-8. PubMed ID: 11559948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia.
    Loh ML; Silverman LB; Young ML; Neuberg D; Golub TR; Sallan SE; Gilliland DG
    Blood; 1998 Dec; 92(12):4792-7. PubMed ID: 9845546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
    Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
    Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse of TEL-AML1--positive acute lymphoblastic leukemia in childhood: a matched-pair analysis.
    Seeger K; von Stackelberg A; Taube T; Buchwald D; Körner G; Suttorp M; Dörffel W; Tausch W; Henze G
    J Clin Oncol; 2001 Jul; 19(13):3188-93. PubMed ID: 11432885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the TEL-AML1 fusion gene in pediatric acute lymphoblastic leukemia in Turkey.
    Ozbek U; Sirma S; Agaoglu L; Yuksel L; Anak S; Yildiz I; Devecioglu O; Timur C; Meral A; Gedikoglu G
    J Pediatr Hematol Oncol; 2003 Mar; 25(3):204-8. PubMed ID: 12621238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification.
    Maloney K; McGavran L; Murphy J; Odom L; Stork L; Wei Q; Hunger S
    Leukemia; 1999 Nov; 13(11):1708-12. PubMed ID: 10557042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of TEL-AML1 transcript in acute lymphoblastic leukemia in long-term remission.
    Endo C; Oda M; Nishiuchi R; Seino Y
    Pediatr Int; 2003 Jun; 45(3):275-80. PubMed ID: 12828580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
    Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
    Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
    Tiensiwakul P
    Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
    Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
    Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells.
    Krishna Narla R; Navara C; Sarquis M; Uckun FM
    Leuk Lymphoma; 2001 May; 41(5-6):615-23. PubMed ID: 11378579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
    McLean TW; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler HP; Takeuchi S; Janssen JW; Seriu T; Bartram CR; Sallan SE; Gilliland DG; Golub TR
    Blood; 1996 Dec; 88(11):4252-8. PubMed ID: 8943861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.